195 related articles for article (PubMed ID: 20402816)
1. Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin.
Cetinkaya ZA; Sezikli M; Güzelbulut F; Coşgun S; Düzgün S; Kurdaş OO
Helicobacter; 2010 Apr; 15(2):143-7. PubMed ID: 20402816
[TBL] [Abstract][Full Text] [Related]
2. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.
Sezgin O; Altintaş E; Nayir E; Uçbilek E
Helicobacter; 2007 Dec; 12(6):629-32. PubMed ID: 18001405
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Helicobacter pylori eradication rates of standard 14-day quadruple treatment and novel modified 10-day, 12-day and 14-day sequential treatments.
Sapmaz F; Kalkan IH; Güliter S; Atasoy P
Eur J Intern Med; 2014 Mar; 25(3):224-9. PubMed ID: 24268371
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two different treatment protocols in Helicobacter pylori eradication.
Nadir I; Yonem O; Ozin Y; Kilic ZM; Sezgin O
South Med J; 2011 Feb; 104(2):102-5. PubMed ID: 21206418
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
7. The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey.
Aydin A; Oruc N; Turan I; Ozutemiz O; Tuncyurek M; Musoglu A
Helicobacter; 2009 Dec; 14(6):520-4. PubMed ID: 19889069
[TBL] [Abstract][Full Text] [Related]
8. Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.
Sezikli M; Çetinkaya ZA; Güzelbulut F; Yeşil A; Coşgun S; Kurdaş OÖ
J Clin Pharm Ther; 2012 Jun; 37(3):282-5. PubMed ID: 21740452
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
[TBL] [Abstract][Full Text] [Related]
10. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.
Kwon JH; Lee DH; Song BJ; Lee JW; Kim JJ; Park YS; Kim N; Jeong SH; Kim JW; Lee SH; Hwang JH; Jung HC; Song IS
Helicobacter; 2010 Apr; 15(2):148-53. PubMed ID: 20402817
[TBL] [Abstract][Full Text] [Related]
11. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
12. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
14. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan.
Tsay FW; Tseng HH; Hsu PI; Wang KM; Lee CC; Chang SN; Wang HM; Yu HC; Chen WC; Peng NJ; Lai KH; Wu DC
J Gastroenterol Hepatol; 2012 Mar; 27(3):498-503. PubMed ID: 21871025
[TBL] [Abstract][Full Text] [Related]
15. Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection.
Kadayifci A; Uygun A; Kilciler G; Kantarcioglu M; Kara M; Ozcan A; Emer O
Helicobacter; 2012 Apr; 17(2):121-6. PubMed ID: 22404442
[TBL] [Abstract][Full Text] [Related]
16. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
17. Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients.
Demir M; Göktürk S; Oztürk NA; Serin E; Yilmaz U
Digestion; 2010; 82(1):47-53. PubMed ID: 20410684
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
[TBL] [Abstract][Full Text] [Related]
19. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
Liao XM; Nong GH; Chen MZ; Huang XP; Cong YY; Huang YY; Wu BH; Wei JQ
World J Gastroenterol; 2015 May; 21(20):6310-6. PubMed ID: 26034367
[TBL] [Abstract][Full Text] [Related]
20. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.
Oh HS; Lee DH; Seo JY; Cho YR; Kim N; Jeoung SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Cho HJ; Jung HC; Song IS
J Gastroenterol Hepatol; 2012 Mar; 27(3):504-9. PubMed ID: 21916989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]